Evaluation of GARP immunohistochemical expression in papillary thyroid carcinoma.

Autor:	Atia, Esraa Adel Mahmoud Mohamed, Sammour, Sanaa Abd Elmaged, Ibrahim, Eman Abdel-Salam, Abou Gabal, Hoda Hassan, Elgohary, Shimaa Abdelraouf
Předmět:	CROSS-sectional method EPITHELIAL cells THYROID gland tumors T cells DATA analysis RECEIVER operating characteristic curves PAPILLARY carcinoma IMMUNOTHERAPY PARAMETERS (Statistics) KRUSKAL-Wallis Test FISHER exact test MANN Whitney U Test DESCRIPTIVE statistics IMMUNOHISTOCHEMISTRY GENE expression MATHEMATICAL statistics MEMBRANE glycoproteins ANALYSIS of variance STATISTICS COMPARATIVE studies STAINS & staining (Microscopy) MICROSCOPY DATA analysis software REGULATORY T cells NONPARAMETRIC statistics
Zdroj:	Egyptian Journal of Otolaryngology; 9/30/2024, Vol. 40 Issue 1, p1-11, 11p
Abstrakt:	Background: Glycoprotein A repetitions predominant (GARP) is a novel transmembrane protein highly expressed on the surface of regulatory T cells (Tregs), which are a subset of immunosuppressive T lymphocytes that play a major role in inhibiting the antitumor immune response. Many studies documented increased GARP expression in various tumors, which is related to a poorer prognosis, and only one single paper investigated its expression in thyroid tumors. Aim: To evaluate the immunohistochemical expression of GARP in differentiated thyroid carcinomas and their tumor-infiltrating lymphocytes (TILs) in comparison to its expression in other benign and low-risk lesions. Methods: Sixty-nine cases of different thyroid lesions were subgrouped into 37 cases of malignant thyroid neoplasms, 25 cases of benign thyroid lesions, and 7 cases of low-risk neoplasms collected from the Pathology Department Laboratories of Ain Shams University Hospitals during the period from January 2017 to December 2021 and stained immunohistochemically for GARP. Immunohistochemical (IHC) results were evaluated in thyroid epithelial cells and TILs. The expression of GARP was correlated with the different clinicopathological parameters. Results: GARP expression discloses a significant statistical difference between the three studied groups (P < 0.001). High GARP expression was detected in 89.19% of the malignant cases and in 28.57% of low-risk neoplasms, while all benign lesions exhibited low GARP expression. High GARP expression of TILs was detected in 60% of the malignant cases. Synchronous high GARP expression in tumor tissue and in the surrounding TILs was detected in 63.16% of the malignant cases, yet these results did not reach statistical significance. Conclusion: GARP is a marker of Tregs, whose high expression is increased in malignant over benign and low-risk lesions. It might be a potential novel target for anticancer immunotherapy. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink